Cite
HARVARD Citation
Stevenson, M. (2016) Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only : systematic review and economic evaluation. [Online]. Southampton : NIHR Journals Library. Available from: http://access.bl.uk/ark:/81055/vdc_100038748589.0x000001